approved April 2026 Metformin (metformin) First-line oral treatment for Type 2 diabetes Jardiance (empagliflozin) SGLT2 inhibitor for Type 2 diabetes Farxiga (dapagliflozin) SGLT2 inhibitor for Type 2 diabetes Cholesterol & Cardiovascular Atorvastatin (atorvastatin) High cholesterol management Rosuvastatin (rosuvastatin) High cholesterol management Livalo (pitavastatin) High cholesterol with fewer drug interactions Ezetimibe (ezetimibe) Cholesterol absorption inhibitor Praluent (alirocumab) PCSK9 inhibitor for high cholesterol Repatha (evolocumab) PCSK9 inhibitor for high cholesterol Amlodipine (amlodipine) High blood pressure management Thyroid & Metabolic Levothyroxine (levothyroxine) Hypothyroidism treatment Synthroid (levothyroxine) Brand thyroid hormone replacement Rezdiffra (resmetirom) Metabolic liver disease (MASH/NASH) Partner with Klinic in Metabolic Health Klinic operates one of the most comprehensive telehealth platforms for metabolic health, covering Type 2 diabetes, obesity and weight management, cardiovascular risk, thyroid disorders, and metabolic liver disease
Safety, Eligibility, and When Medical Supervision Is Essential Compounded semaglutide requires ongoing medical supervision to monitor efficacy, side effects, and metabolic changes
1 Increased GH levels have also been implicated in cancer and diabetes
Instead, GlyNAC provides glycine and cysteine to support cellular GSH synthesis and concentrations, and supports the cellular ability to autoregulate its redox milieu in every organ and tissue
